CTLA4 and neoplasm: Immune checkpoints like PD-1, PD-L1, and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) are a group of regulatory molecules that limit the damage caused by immune responses to normal tissues, and are also used by tumor cells to escape immune surveillance (128–130).